BackTien Liang BioTech , Ltd. Overview

Tien Liang BioTech , Ltd. Total Current Liabilities

Track Tien Liang BioTech , Ltd.'s total current liabilities ($700M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$704.01M
↑ 16.20% YoYΔ $98.16M vs prior year quarter

Peer trimmed avg / median

Loading

Tien Liang BioTech , Ltd. Total Current Liabilities History

Loading

Tien Liang BioTech , Ltd. vs. peers: Total Current Liabilities Comparison

Loading

Tien Liang BioTech , Ltd. Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Tien Liang BioTech , Ltd. (4127.TWO) FAQ

As of the most recent data (June 2026), 4127.TWO shows a total current liabilities of $700M. That compares with $610M in the prior-year period — up 16.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4127.TWO's total current liabilities is now $700M (was $610M) — a 16.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Tien Liang BioTech , Ltd. is outperforming or lagging.

Tracking 4127.TWO's total current liabilities over time shows whether Tien Liang BioTech , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $700M That compares with $610M in the prior-year period — up 16.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Tien Liang BioTech , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $700M) with ownership activity and broader fundamentals.